Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Zach Weinberg
AddedMar 31, 2024
UpdatedJul 16, 2026
Zach Weinberg

Zach Weinberg

Co-Founder & CEO, Curie.Bio

CrunchbaseLinkedIn

Zach Weinberg's Career

Curie.Bio
Curie.Bio

Boston, MA, US

Co-Founder & CEO· C-Suite · Management
Flatiron Health
Flatiron Health

New York City, NY, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Zach Weinberg's Career

Curie.Bio
Curie.Bio
Series B262022Boston, MA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Curie.Bio

Christoph LengauerChristoph LengauerCo-Founder
Alexis BorisyAlexis BorisyBoard Member

Similar to Curie.Bio

Bioventure PartnersBioventure PartnersChapel Hill, NC, USAdvisory, InvestmentBioventure PartnersChapel Hill, NC, US

Bioventure Partners: Investing in and advising high-impact, tech-driven life science startups.

4
BiotechonomyBiotechonomyNewton, MA, USBiotechonomyNewton, MA, US

Biotechonomy: A venture capital firm specializing in equity financing and management aid for innovative life science startups.

6
Curi BioCuri BioSeattle, WA, USBiotech, Drug Discoveryest. 2015Curi BioSeattle, WA, US · est. 2015

Curi Bio: Accelerating next-gen medicine discovery through human cells, systems, and data integration.

Series A · $20.4M45
Orchid BioVenturesOrchid BioVenturesRockville, MD, USBiotechest. 2020Orchid BioVenturesRockville, MD, US · est. 2020

Orchid BioVentures: A venture studio advancing novel biotech solutions for unmet patient needs.

Pre-Seed · $480k30
Flatiron Health
Flatiron Health
Series D$324.9M1.9k2012New York City, NY, US
Co-Founder

Leadership at Flatiron Health

Krishna YeshwantKrishna YeshwantBoard Member
Carolyn StarrettCarolyn StarrettCEO
Daniel O'DayDaniel O'DayBoard Member
Nat TurnerNat TurnerBoard Member
Dr Andrew J Conrad PhDDr Andrew J Conrad PhDBoard Member

Zach Weinberg's Co-Investors

Lee ShapiroLee ShapiroCo-invested · Iterative Scopes Series ANat TurnerNat TurnerCo-invested · Iterative Scopes Series AAssaf WandAssaf WandCo-invested · Connie Health Series AGinny FahsGinny FahsCo-invested · HumanFirst Series AAlice ZhangAlice ZhangCo-invested · HumanFirst Series AJessica ColeJessica ColeCo-invested · HumanFirst Series AReade FahsReade FahsCo-invested · HumanFirst Series AJamie GatesJamie GatesCo-invested · HumanFirst Series A

Zach Weinberg's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Zach Weinberg

Michael AgustinMichael AgustinCEO · Weaver LabsDan TangDan TangCEO · Curie LondonHillary LinHillary LinCo-Founder · CurioErika MilczekErika MilczekFounder · CurieSuzanne DavisSuzanne DavisCEO · Cuurio